This table presents recent patent oppositions filed by Generics (u.k.) Limited against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP4159204Novel Pharmaceutical CompositionNOVARTIS AGNov 14, 2024
EP3474820Glp-1 Compositions And Uses ThereofNOVO NORDISK A/SNov 7, 2024
EP3478286Methods Of Treating Ovarian CancerTESARO INC.Oct 3, 2024
EP2968301Combination Of Two Antivirals For Treating Hepatitis CABBVIE INC.Jan 19, 2018
EP2197478Use Of Glp-1 Analogues For The Treatment Of Disorders Associated With Dysfunctional Synaptic TransmissionUUTECH LIMITEDJan 18, 2018
EP2762140Treatment Of Solid Brain Tumours With A Rapamycin DerivativeNOVARTIS AGDec 22, 2017
EP2854768Pharmaceutical Compositions Of PemetrexedFRESENIUS KABI ONCOLOGY LIMITEDDec 22, 2017
EP2637664Compositions And Methods Of Treating Pulmonary HypertensionGILEAD SCIENCES, INC.Dec 21, 2017
EP2332934Chrystals Including A Malic Acid Salt Of N-[2-(Diethylamino)Ethyl]-5-[(5-Fluoro-1,2-Dihydro-2-Oxo-3H-Indole-3-Ylidene)Methyl]-2,4-Dimethyl-1H-Pyrrole-3-Carboxamide, Processes For Its Preparation And Compositions ThereofPHARMACIA & UPJOHN COMPANY LLCNov 30, 2017
EP2501384Method Of Treating Proliferative Disorders And Other Pathological Conditions Mediated By Bcr-Abl, C-Kit, Ddr1, Ddr2 Or Pdgf-R Kinase ActivityNOVARTIS AGNov 17, 2016